Policy Blog

A perfect storm: federal shutdown furloughs 32,000+ HHS staff and halts FDA approvals, Medicare Advantage enrollment drops amid premium cuts, Trump’s drug pricing deals draw widespread skepticism, and millions face insurance cost spikes as Congress battles over ACA subsidies.

HS Secretary Robert F. Kennedy Jr. faces an unprecedented crisis of confidence as bipartisan lawmakers, over 1,000 federal employees, medical societies, and his own family demand his resignation amid controversial vaccine policies and CDC leadership upheaval.

This week: With at least six top leaders resigning, congressional hearings underway, and former CDC directors warning of dangers to American health, the crisis threatens to fundamentally reshape the nation’s disease surveillance and emergency response capabilities.

This week: federal health agencies face unprecedented upheaval as the Supreme Court upholds $783 million in NIH cuts, HHS Secretary RFK Jr. drives sweeping reforms amid employee revolt, and major medical societies openly defy CDC guidance—signaling a fundamental restructuring of American healthcare policy that will reshape everything from drug approvals to patient care standards.

This week: Healthcare AI explodes with 38.5% market growth while paradoxically “deskilling” providers, as the Trump administration’s vaccine policy reversals and MAHA initiative pivot spark scientific controversy.

This week: Prasad does the Hokey Pokey at CBER as MAHA continues to take root across federal programs.

This Week: From Medicare’s potential $2.5 billion in savings through service cuts and the FDA’s leadership exodus to NIH funding slashed to just 4% of applications and Trump’s drug pricing ultimatum, seismic policy shifts and financial upheavals are reshaping every corner of America’s healthcare landscape.